BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32057901)

  • 1. Decreasing Arl4c expression by inhibition of AKT signal in human lung adenocarcinoma cells.
    Sun Y; Zhang Z; Xiang F; Zhang M; Chen Q; Tang L; Zhu L; Liu J; Meng Z; Hu J; Luo X; Ni Z; Wang X
    Life Sci; 2020 Apr; 246():117428. PubMed ID: 32057901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination treatment with triptolide and hydroxycamptothecin synergistically enhances apoptosis in A549 lung adenocarcinoma cells through PP2A-regulated ERK, p38 MAPKs and Akt signaling pathways.
    Meng G; Wang W; Chai K; Yang S; Li F; Jiang K
    Int J Oncol; 2015 Mar; 46(3):1007-17. PubMed ID: 25573072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARL4C stabilized by AKT/mTOR pathway promotes the invasion of PTEN-deficient primary human glioblastoma.
    Chen Q; Weng HY; Tang XP; Lin Y; Yuan Y; Li Q; Tang Z; Wu HB; Yang S; Li Y; Zhao XL; Fu WJ; Niu Q; Feng H; Zhang X; Wang Y; Bian XW; Yao XH
    J Pathol; 2019 Feb; 247(2):266-278. PubMed ID: 30357833
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Lu XX; Cao LY; Chen X; Xiao J; Zou Y; Chen Q
    Biomed Res Int; 2016; 2016():2476842. PubMed ID: 27822469
    [No Abstract]   [Full Text] [Related]  

  • 5. XPC inhibition rescues cisplatin resistance via the Akt/mTOR signaling pathway in A549/DDP lung adenocarcinoma cells.
    Teng X; Fan XF; Li Q; Liu S; Wu DY; Wang SY; Shi Y; Dong M
    Oncol Rep; 2019 Mar; 41(3):1875-1882. PubMed ID: 30628719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursolic acid inhibits the metastasis of colon cancer by downregulating ARL4C expression.
    Zhang M; Xiang F; Sun Y; Liu R; Li Q; Gu Q; Kang X; Wu R
    Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38131251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High expression of VEGFR3 is positively associated with poor prognosis in lung adenocarcinoma].
    Li J; Zhang W; Xia H; Liu Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):1023-1029. PubMed ID: 31878999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties.
    Xu Y; Jiang Z; Zhang Z; Sun N; Zhang M; Xie J; Li T; Hou Y; Wu D
    J Cell Biochem; 2014 Jun; 115(6):1112-21. PubMed ID: 24356998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic upregulation of ARL4C, due to DNA hypomethylation in the 3'-untranslated region, promotes tumorigenesis of lung squamous cell carcinoma.
    Fujii S; Shinjo K; Matsumoto S; Harada T; Nojima S; Sato S; Usami Y; Toyosawa S; Morii E; Kondo Y; Kikuchi A
    Oncotarget; 2016 Dec; 7(49):81571-81587. PubMed ID: 27835592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway.
    Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P
    Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of different components from Ophiopogon japonicus on autophagy in human lung adenocarcinoma A549Cells through PI3K/Akt/mTOR signaling pathway.
    Chen J; Yuan J; Zhou L; Zhu M; Shi Z; Song J; Xu Q; Yin G; Lv Y; Luo Y; Jia X; Feng L
    Biomed Pharmacother; 2017 Mar; 87():118-126. PubMed ID: 28049093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target.
    Fujii S; Matsumoto S; Nojima S; Morii E; Kikuchi A
    Oncogene; 2015 Sep; 34(37):4834-44. PubMed ID: 25486429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma.
    Song YH; Zhang CQ; Chen FF; Lin XY
    Chin Med J (Engl); 2018 Jan; 131(1):16-24. PubMed ID: 29271375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemosensitizing effect of Paris Saponin I on Camptothecin and 10-hydroxycamptothecin in lung cancer cells via p38 MAPK, ERK, and Akt signaling pathways.
    Liu Z; Zheng Q; Chen W; Wu M; Pan G; Yang K; Li X; Man S; Teng Y; Yu P; Gao W
    Eur J Med Chem; 2017 Jan; 125():760-769. PubMed ID: 27721159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.
    Saurabh K; Shah PP; Doll MA; Siskind LJ; Beverly LJ
    BMC Cancer; 2020 Aug; 20(1):824. PubMed ID: 32867711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARL4C is associated with initiation and progression of lung adenocarcinoma and represents a therapeutic target.
    Kimura K; Matsumoto S; Harada T; Morii E; Nagatomo I; Shintani Y; Kikuchi A
    Cancer Sci; 2020 Mar; 111(3):951-961. PubMed ID: 31925985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth.
    Liu L; Yan H; Ruan M; Yang H; Wang L; Lei B; Sun X; Chang C; Huang G; Xie W
    Cancer Sci; 2021 Aug; 112(8):3083-3098. PubMed ID: 34033176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXM1 confers resistance to gefitinib in lung adenocarcinoma via a MET/AKT-dependent positive feedback loop.
    Wang Y; Zhang W; Wen L; Yang H; Wen M; Yun Y; Zhao L; Zhu X; Tian L; Luo E; Li Y; Liu W; Wen N
    Oncotarget; 2016 Sep; 7(37):59245-59259. PubMed ID: 27494877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIF18B as a regulator in microtubule movement accelerates tumor progression and triggers poor outcome in lung adenocarcinoma.
    Ji Z; Pan X; Shang Y; Ni DT; Wu FL
    Tissue Cell; 2019 Dec; 61():44-50. PubMed ID: 31759406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of TGF-β signaling blockade on human A549 lung adenocarcinoma cell lines.
    Xu CC; Wu LM; Sun W; Zhang N; Chen WS; Fu XN
    Mol Med Rep; 2011; 4(5):1007-15. PubMed ID: 21725601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.